News & Stories

Immerse yourself in the fascinating world of a leading science and technology company. Explore the latest news from the media center and stay up-to-date with our upcoming events.

On the war in Ukraine

Statement by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany, on behalf of the Executive Board.

Read here

Latest News

View all news
  1. Press Releases

    MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems ...

    Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.

    2022/12/06

  2. Press Releases

    European Medicines Agency (EMA) Validates Application for Arpraziquantel to ...

    Merck KGaA, Darmstadt, Germany and the Pediatric Praziquantel Consortium, announced that the EMA has validated for review the application for arpraziquantel for the treatment of schistosomiasis in preschool.

    2022/12/02

  3. Press Releases

    Merck KGaA, Darmstadt, Germany Aims to Double R&D Productivity in Oncology ...

    Merck KGaA today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity.

    2022/11/21

Get the latest news!

If you are interested in getting frequent company updates via email, feel free to subscribe to our press release service.
Subscribe

Key figures

Our excellent performance is measure and shown by several key figures, more information are stored in our investors section.

  • 19bn

    Net sales €19.7 billion

  • 6.1bn

    EBITDA pre €6.1 billion

  • 62K

    Around 62,770 Employees

Upcoming Events

View All Events